Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A malignant mesenchymal neoplasm arising from the wall of the uterine corpus (uterine body). The most representative examples are leiomyosarcoma and endometrial stromal sarcoma.
10 clinical trials registered, 3 recruiting. Interventions under study include other interventions, procedural interventions, drug therapy, and gene therapy. Pipeline includes 1 PHASE3, 1 PHASE2, 1 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT03422198](https://clinicaltrials.gov/study/NCT03422198) |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:11 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer |
PHASE3 |
University of Utah |
RECRUITING |
[NCT06805019](https://clinicaltrials.gov/study/NCT06805019) | Construction of a Model for the Differential Diagnosis of SArcoma/myoma Based on the RAdiomics Features: Single-center Observational Study | — | IRCCS Azienda Ospedaliero-Universitaria di Bologna | RECRUITING |
[NCT00005095](https://clinicaltrials.gov/study/NCT00005095) | Specimen and Data Study for Ovarian Cancer Early Detection and Prevention | — | Northwestern University | RECRUITING |
14 publications have been identified in PubMed for uterine corpus sarcoma. Research spans Case Report / Case Series (57%), Review / Meta-Analysis (29%), and Basic Science / Preclinical (7%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 8 | 57% |
Research summaries | 4 | 29% |
Laboratory research | 1 | 7% |
Disease patterns and progression | 1 | 7% |
Agaimy A (2026). [PMID: 41555057](https://pubmed.ncbi.nlm.nih.gov/41555057/). *Virchows Archiv : an international journal of pathology*. [Review / Meta-Analysis]
Özmaskan F (2026). [PMID: 41773223](https://pubmed.ncbi.nlm.nih.gov/41773223/). *International journal of women's health*. [Epidemiology / Natural History]
Lee JY (2026). [PMID: 41617092](https://pubmed.ncbi.nlm.nih.gov/41617092/). *Toxicology and applied pharmacology*. [Basic Science / Preclinical]
Papke DJ (2025). [PMID: 40462401](https://pubmed.ncbi.nlm.nih.gov/40462401/). *Histopathology*. [Case Report / Case Series]
Kanao S (2025). [PMID: 39896229](https://pubmed.ncbi.nlm.nih.gov/39896229/). *Fujita medical journal*. [Case Report / Case Series]
Utsunomiya-Nishimizu R (2025). [PMID: 40124770](https://pubmed.ncbi.nlm.nih.gov/40124770/). *International medical case reports journal*. [Case Report / Case Series]
Sehra D (2025). [PMID: 39848787](https://pubmed.ncbi.nlm.nih.gov/39848787/). *BMJ case reports*. [Case Report / Case Series]
Zhang XY (2025). [PMID: 39729556](https://pubmed.ncbi.nlm.nih.gov/39729556/). *International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists*. [Review / Meta-Analysis]
Prabhat P (2025). [PMID: 40861708](https://pubmed.ncbi.nlm.nih.gov/40861708/). *Cureus*. [Case Report / Case Series]
Canaan LN (2025). [PMID: 41613719](https://pubmed.ncbi.nlm.nih.gov/41613719/). *Cureus*. [Case Report / Case Series]
AI-curated news mentioning uterine corpus sarcoma
Updated May 6, 2026
A study highlights the 'quiet genome' concept in SMARCA4-deficient uterine sarcoma through whole-exome sequencing, showcasing a highly aggressive case in a young woman. This research may provide insights into the genetic underpinnings of this rare cancer type.